MOH Research Note — Medical Costs Stay Unresolved
Molina's raised outlook faces a 92.2% medical-cost ratio, a 57% ACA membership decline and weak price structure.
Managed Care
MOH Deep Coverage Review — Analysis as of August 3, 2026
Molina's earnings beat faces a 92.2% medical-cost ratio, a 57% ACA membership decline and unresolved valuation evidence.
MOH Research Note — The Beat Masks Strain
Molina’s earnings beat and raised outlook face a harder test from weak premium revenue, declining membership and sharply compressed margins.
MOH Deep Coverage Review — Analysis as of July 27, 2026
Molina’s earnings beat masks weaker premium revenue, declining membership and compressed margins while the shares lag a strong health-care tape.
UNH Research Note — Better Headlines, Unresolved Costs
UnitedHealth’s better quarter did not settle the medical-cost debate as the shares reversed sharply despite broader health-care leadership.
UNH Deep Coverage Review — Analysis as of July 27, 2026
UnitedHealth’s valuation and dividend support the franchise, but medical-cost uncertainty and a failed breakout leave stabilization unconfirmed.